Literature DB >> 30087419

Germline duplication of ATG2B and GSKIP genes is not required for the familial myeloid malignancy syndrome associated with the duplication of chromosome 14q32.

Daria V Babushok1,2, Natasha L Stanley3, Jennifer J D Morrissette4, David B Lieberman4, Timothy S Olson3,5, Stella T Chou6, Elizabeth O Hexner7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30087419      PMCID： PMC6301065          DOI： 10.1038/s41375-018-0231-9

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Densely interconnected transcriptional circuits control cell states in human hematopoiesis.

Authors:  Noa Novershtern; Aravind Subramanian; Lee N Lawton; Raymond H Mak; W Nicholas Haining; Marie E McConkey; Naomi Habib; Nir Yosef; Cindy Y Chang; Tal Shay; Garrett M Frampton; Adam C B Drake; Ilya Leskov; Bjorn Nilsson; Fred Preffer; David Dombkowski; John W Evans; Ted Liefeld; John S Smutko; Jianzhu Chen; Nir Friedman; Richard A Young; Todd R Golub; Aviv Regev; Benjamin L Ebert
Journal:  Cell       Date:  2011-01-21       Impact factor: 41.582

2.  Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies.

Authors:  Joseph Saliba; Cécile Saint-Martin; Antonio Di Stefano; Gaëlle Lenglet; Caroline Marty; Boris Keren; Florence Pasquier; Véronique Della Valle; Lise Secardin; Gwendoline Leroy; Emna Mahfoudhi; Sarah Grosjean; Nathalie Droin; M'boyba Diop; Philippe Dessen; Sabine Charrier; Alberta Palazzo; Jane Merlevede; Jean-Côme Meniane; Christine Delaunay-Darivon; Pascal Fuseau; Françoise Isnard; Nicole Casadevall; Eric Solary; Najet Debili; Olivier A Bernard; Hana Raslova; Albert Najman; William Vainchenker; Christine Bellanné-Chantelot; Isabelle Plo
Journal:  Nat Genet       Date:  2015-08-17       Impact factor: 38.330

Review 3.  Universal genetic testing for inherited susceptibility in children and adults with myelodysplastic syndrome and acute myeloid leukemia: are we there yet?

Authors:  Kiran Tawana; Michael W Drazer; Jane E Churpek
Journal:  Leukemia       Date:  2018-02-27       Impact factor: 11.528

4.  BloodSpot: a database of gene expression profiles and transcriptional programs for healthy and malignant haematopoiesis.

Authors:  Frederik Otzen Bagger; Damir Sasivarevic; Sina Hadi Sohi; Linea Gøricke Laursen; Sachin Pundhir; Casper Kaae Sønderby; Ole Winther; Nicolas Rapin; Bo T Porse
Journal:  Nucleic Acids Res       Date:  2015-10-26       Impact factor: 16.971
  4 in total
  3 in total

1.  Loss of Atg2b and Gskip Impairs the Maintenance of the Hematopoietic Stem Cell Pool Size.

Authors:  Shun-Suke Sakai; Atsushi Hasegawa; Ryosuke Ishimura; Naoki Tamura; Shun Kageyama; Satoko Komatsu-Hirota; Manabu Abe; Yiwei Ling; Shujiro Okuda; Manabu Funayama; Mika Kikkawa; Yoshiki Miura; Kenji Sakimura; Ichiei Narita; Satoshi Waguri; Ritsuko Shimizu; Masaaki Komatsu
Journal:  Mol Cell Biol       Date:  2021-11-08       Impact factor: 4.272

2.  Germline ERBB2/HER2 Coding Variants Are Associated with Increased Risk of Myeloproliferative Neoplasms.

Authors:  Evan M Braunstein; Hang Chen; Felicia Juarez; Fanghan Yang; Lindsay Tao; Igor Makhlin; Donna M Williams; Shruti Chaturvedi; Aparna Pallavajjala; Theodoros Karantanos; Renan Martin; Elizabeth Wohler; Nara Sobreira; Christopher D Gocke; Alison R Moliterno
Journal:  Cancers (Basel)       Date:  2021-06-29       Impact factor: 6.639

3.  Germline ATG2B/GSKIP-containing 14q32 duplication predisposes to early clonal hematopoiesis leading to myeloid neoplasms.

Authors:  Jean Pegliasco; Pierre Hirsch; Christophe Marzac; Françoise Isnard; Jean-Côme Meniane; Caroline Deswarte; Philippe Pellet; Céline Lemaitre; Gwendoline Leroy; Graciela Rabadan Moraes; Hélène Guermouche; Barbara Schmaltz-Panneau; Florence Pasquier; Chrystelle Colas; Patrick R Benusiglio; Odile Bera; Jean-Henri Bourhis; Eolia Brissot; Olivier Caron; Samy Chraibi; Pascale Cony-Makhoul; Christine Delaunay-Darivon; Simona Lapusan; Flore Sicre de Fontbrune; Pascal Fuseau; Albert Najman; William Vainchenker; François Delhommeau; Jean-Baptiste Micol; Isabelle Plo; Christine Bellanné-Chantelot
Journal:  Leukemia       Date:  2021-06-25       Impact factor: 11.528
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.